Clinical trial
A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of…
NCT02378844 · ElectroCore INC, Industry · Completed
Key facts
| NCT number | NCT02378844 |
|---|---|
| Title | A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of Episodic Migraine |
| Official title | A Randomized, Multicentre, Double-blind, Parallel, Sham-controlled Study of gammaCore®, a Non-invasive Vagal Nerve Stimulator (nVNS), for Prevention of Episodic Migraine |
| Lead sponsor | ElectroCore INC, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Device |
| Interventions | gammaCore®-R, gammaCore®-R Sham |
| Enrollment | 477 |
| Start date | Jun 1, 2015 |
| Primary completion | Feb 1, 2018 |
| Completion | Aug 29, 2018 |
| First posted | Mar 4, 2015 |
| Last update posted | Aug 19, 2019 |
| Countries | Belgium, Denmark, Germany, Greece, Netherlands, Norway, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: